Results
1 -
10 of
159Successful and Well-Tolerated Second Line Therapy with Cetuximab, Irinotecan, and Raltitrexed in Progressive Liver Disease Due to Metastatic Colon Cancer, Journal of Gastrointestinal Cancer Second-Line Chemotherapy, Malignant Mesothelioma Novel chemotherapy agents for colorectal cancer: Oral fluoropyrimidines, oxaliplatin, and raltitrexed, Current Oncology Reports Preclinical development of Alimta??? (Pemetrexed, LY231514), a multitargeted antifolate, Advances in Targeted Cancer Therapy